Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Pharma Industry News Quoin Pharmaceuticals (NASDAQ: QNRX) spikes over 50% after rapamycin breakthrough in rare disease program Quoin Pharmaceuticals (NASDAQ: QNRX) stock surged over 50% after achieving key rapamycin delivery targets. Find out how this positions its rare disease pipeline. byVenkateshNovember 11, 2025